E. Bargagli (Siena, Italy), S. Freitas (Coimbra, Portugal), R. P. Baughman (Cincinnati, United States of America)
Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis
H. N. A. J. van Rijswijk, A. D. M. Vorselaars, I. H. E. Korenromp, H. J. T. Ruven, R. G. M. Keijsers, J. C. Grutters (Nieuwegein, ‘s Hertogenbosch, Utrecht, Netherlands)
|  |
Many faces of neursarcoidosis!
N. Marçal, M. Aguiar, J. Pimentel, I. Claro, A. C. Mendes, A. Bugalho de Almeida (Lisbon, Portugal)
|  |
Evaluation of factors affecting mortality rate in sarcoidosis
E. Gialafos, V. Kouranos, A. Kallianos, T. David, T. Papaioannou, S. Stampola, E. Peros, I. Arapis, C. Kostopoulos, G. Mpirmpa, J. Gialafos, A. Rapti (Athens, Greece)
| |
Long-term treatment with infliximab in patients with sarcoidosis
K. Hostettler, U. Studler, M. Tamm, M. Brutsche (Basel, Switzerland)
| |
Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis?
N. Milman, C. B. Svendsen, B. Søborg, A. B. Andersen (Copenhagen, Denmark)
| |
Honeycombing pattern: A particular form of sarcoidosis-related pulmonary fibrosis
A. Herve, P. Y. Brillet, D. Bouvry, O. Freynet, J. M. Naccache, M. Kambouchner, M. Brauner, D. Valeyre, H. Nunes (Bobigny, France)
| |
Thyroid disease in an Irish cohort of sarcoidosis patients
M. McDonnell, I. Suleem, R. Rutherford, A. O‘Regan, J. J. Gilmartin (Galway, Ireland)
| |
Pulmonary hypertension and right ventricular impairment in patients with sarcoidosis
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis
M. Lebedeva, I. Popova, E. Popova, A. Ponomarev, E. Arion (Moscow, Russian Federation; Moscow, Reunion)
| |
Diagnostic value of epithelioid cell granulomas in bronchoscopic biopsies
E. Danila, E. Zurauskas, R. Zablockis, V. Gruslys (Vilnius, Lithuania)
| |
Is sarcoidosis associated with increased occurrence of malignancy? A retrospective analysis
M. Doubkova, I. Binkova, J. Skrickova (Brno, Czech Republic)
| |
QRS-T angle significantly increased in sarcoidosis patients
E. Gialafos, A. Kallianos, V. Kouranos, M. Ntouskou, E. Taktikou, E. Peros, L. Velentza, G. Dionellis, C. Kostopoulos, G. Mathioudakis, I. Arapis, G. Tzelepis, A. Rapti (Athens, Greece)
| |
Hard diagnosis of intrathoracic sarcoidosis in male patients
M. Zarrouk, N. Ben Salem, N. Chaouch, M. Loukil, S. Cheikh Rouhou, H. Racil, K. Marnich, A. Chabbou (Ariana, Tunis, Tunisia)
| |
Corticosteroids significantly improve symptom score in patients with active pulmonary sarcoidosis over a two year follow up
H. Milburn, A. Warrington (London, United Kingdom)
| |
Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis
M. Lebedeva, E. Popova, A. Ponomarev, B. Sergei (Moscow, Russian Federation)
| |
Manifestations of malignancies during the course of sarcoidosis
J. Videnovic-Ivanov, V. Vucinic, S. Filipovic, V. Zugic, J. Stojsic (Belgrade, Republic Of Serbia)
| |
Experience of hydroxychloroquine in the treatment of pulmonary sarcoidosis in the west of Ireland: An insight into clinical practice
M. McDonnell, I. Suleem, R. Rutherford, A. O‘Regan, J. J. Gilmartin (Galway, Ireland)
| |
Characteristics of inflammatory bowel diseases-associated interstitial lung diseases
C. Bron, M. Kambouchner, T. Gille, Y. Uzunhan, J. M. Naccache, P. Y. Brillet, M. Brauner, D. Valeyre, H. Nunes (Bobigny, France)
| |
Characterization of chronic hypersensitivity pneumonitis and evaluation of its predictive factors – Retrospective study
R. Rolo, A. Morais, N. Melo, P. Mota, J. M. Pereira, M. A. Vasconcelos, S. Guimarães, C. Souto-Moura (Braga, Porto, Portugal)
| |
Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis
D. Koschel, C. Cardoso, B. Wiedemann, G. Höffken, M. Halank (Coswig, Dresden, Germany)
| |